Keywords
gujian powder
Extracorporeal shockwave
Femoral head necrosis
Submitted : 2025-04-07
Accepted : 2025-04-22
Published : 2025-05-07
Abstract
Objective: To observe the clinical efficacy of Gujiansan combined with extracorporeal shockwave therapy for early osteonecrosis of the femoral head (ONFH). Methods: Sixty patients with early ONFH were selected and randomly divided into three groups, with 20 cases in each group. The experimental group was treated with oral Gujiansan combined with extracorporeal shockwave therapy. Control group A was treated with Gujiansan orally, while control group B was treated with Xianling Gubao capsules orally. Result: Compared with before treatment, the VAS score, Harris score, and bone density of the experimental group and control groups A and B were significantly improved at 30, 90, and 180 days after treatment, with statistically significant differences. Compared with the control groups A and B, the experimental group showed more significant improvements in VAS score, Harris score, and bone density at 30, 90, and 180 days after treatment, with statistically significant differences. Conclusion: The combination of Gujiansan and extracorporeal shockwave therapy significantly improves VAS score, Harris score, and bone density in patients with early osteonecrosis of the femoral head, effectively reduces pain, and improves patient quality of life. Thus, it is worth promoting in the clinics.
References
Hines JT, Jo WL, Cui Q, et al., 2021, Osteonecrosis of the Femoral Head: An Updated Review of ARCO on Pathogenesis, Staging and Treatment. J Korean Med Sci, 36(24): e177.
Sun HZ, Cai J, Liu X, et al., 2018, Study on Chinese Medicine Combined with Extracorporeal Shockwave for the Treatment of Early Alcoholic Femoral Head Necrosis in the Elderly. Liaoning Journal of Chinese Medicine, 45(11): 2337–2339.
Chinese Clinical Diagnosis and Treatment Guidelines for Adult Femoral Head Necrosis, 2020, Chinese Journal of Orthopedics, 40(20): 1365–1376.
State Administration of Traditional Chinese Medicine, 2012, Diagnostic and Therapeutic Efficacy Standards of Chinese Medicine, China Medical Science and Technology Press, Beijing, 93–94.
Gong W, Zheng H, Yang T, et al., 2019, Effects of Different Fractions of Antler Velvet on Bone Tissue of Rats with De-Osteoporosis and its Mechanism. Chinese Journal of Experimental Formulas, 25(20): 36–42.
Wang Y, Yang Z, Chen Y, et al., 2019, Network Pharmacology Study on the Mechanism of Action of Cistanche for Osteoporosis. Chinese Pharmacy, 30(05): 645–651.
Liu X, Kai L, Sheng B, et al., 2019, Progress of Pharmacological Research on Radix et Rhizoma Ginseng. Journal of Liaoning University of Traditional Chinese Medicine, 21(11): 112–115.
Yang W, Huang J, Wang W, et al., 2022, Investigating the Mechanism of Action of the Active Ingredients of Panax ginseng in the Treatment of Osteoporosis based on Network Pharmacology and In Vitro Cellular Assay. Chinese Journal of Traditional Chinese Medicine, (04): 1087–1097.
Du P, Zhou Y, Huang G, et al., 2017, Research Progress on Chemical Constituents, Pharmacological Effects and Clinical Application of Monomania Plants. Anhui Agricultural Science, 45(06): 109–111.
Li J, Chen S, Ge P, 2022, Progress of Pharmacological Research on Cornus officinalis. Journal of Liaoning University of Traditional Chinese Medicine, 24(04): 63–66.
Wuerfel T, Schmitz C, Jokinen LLJ, 2022, The Effects of the Exposure of Musculoskeletal Tissue to Extracorporeal Shock Waves. Biomedicines, 10(5): 1084.
Cao H, Liu MT, Shi F, 2017, Current Status of Extracorporeal Shock Waves in the Treatment of Early Adult Femoral Head Necrosis. Chinese Journal of Orthopedic Surgery, 25(23): 2165–2168.